Brief Report: Enhancement of Patient Recruitment in Rheumatoid Arthritis Clinical Trials Using a Multi‐Biomarker Disease Activity Score as an Inclusion Criterion

OBJECTIVE: Rheumatoid arthritis (RA) clinical trials often exclude patients who have low C‐reactive protein (CRP) levels, which slows enrollment into the trial. The purpose of this study was to determine whether high Multi‐Biomarker Disease Activity (MBDA) scores (>44) in RA patients with low CRP...

Descripción completa

Detalles Bibliográficos
Autores principales: van Vollenhoven, Ronald F., Bolce, Rebecca, Hambardzumyan, Karen, Saevarsdottir, Saedis, Forslind, Kristina, Petersson, Ingemar F., Sasso, Eric H., Hwang, C. C., Segurado, Oscar G., Geborek, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061088/
https://www.ncbi.nlm.nih.gov/pubmed/26213309
http://dx.doi.org/10.1002/art.39274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061088/
https://www.ncbi.nlm.nih.gov/pubmed/26213309
http://dx.doi.org/10.1002/art.39274

Ejemplares similares